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Abstract  
Adverse effects of dermal facial fillers are increasingly posing a difficult treatment dilemma. Although 
broadly non-toxic synthetic fillers act as foreign bodies in the tissues eliciting a host response, even many 
years after administration. Adverse outcomes, ranging from chronic lymphoplasmacytic inflammatory 
reactions to granulomatous reactions have been documented in the literature1. High aesthetic demands, lack 
of existing scars for access and unavailable treatment history can compound the difficulty. Furthermore, we 
are increasingly encountering adverse effects in patients treated outside the United Kingdom (UK). Here we 
present a case report demonstrating our experience in the management of these problems. 
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Introduction 
Facial rejuvenation with autologous fat has been documented in the literature since 18932. Since then, 
synthetic filler materials have become widely available, and there now exists over one hundred types. 
Dermal fillers can be temporary or permanent, and are used to restore volume and fill wrinkles.  
Fillers are made from purified animal dermal components such as collagen and hyaluronic acid, or 
synthetic materials such as poly-l-lactic acid and calcium hydroxylapatite3. A range of complications 
associated with dermal fillers have been reported in the literature and the media, including immediate 
complications (such as erythema, swelling, and itching), and later complications such as granulomatous 
reactions4. Reasons for these complications may include inappropriate placement of the filler, 
infections and hypersensitivity4. 
A survey conducted in 2012 by the British Association of Aesthetic Plastic Surgeons (BAAPS), 
found that 49% of surgeons who responded had treated problems with semi or permanent facial fillers. 
Of these cases, 84% required corrective surgery5. BAAPS also reported a rise in the range of 25-35% of 
the number of patients suffering complications after treatment outside the UK5.  
We present a case report demonstrating our experience in using surgical methods for successful 
treatment of the adverse effects of injectable dermal facial fillers.  
Case report 
A healthy thirty one year old lady presented to the maxillofacial team complaining of intermittent 
swelling, pain and erythema bilaterally on her face. These symptoms lasted approximately two days at a 
time and occurred every two to three weeks. There did not seem to be any triggering factors for these 
episodes. Seven years previously, the patient had had facial fillers injected bilaterally. The treatment 
had been carried out in the Middle East. On examination she was found to have tender masses at the 
injection sites, including a mass which obliterated the left nasolabial fold (Fig. 1). The lips had also 
been injected. Following clinical examination, she underwent Magnetic Resonance Imaging (MRI) 
scanning. Multiple foreign body deposits were noted, which were concluded to be consistent with 
synthetic silicone filler material (Fig. 1).  
 
 
 
 
 
 
 
 
 
 
 
Fig 1 Clinical and radiographic appearances at presentation 
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The patient was diagnosed with infected dermal facial fillers. It was discussed with the radiology 
department, whether it might be feasible to remove the silicone material via ultrasound guided 
aspiration. However, aspiration techniques were not recommended due to the viscosity of the material 
on ultrasound. She was treated with non-steroidal anti-inflammatory drugs, and received filler removal 
via a facelift approach (Fig. 2). The right and left sides of the face were debrided individually.  
 
 
 
 
 
 
 
 
 
 
Fig. 2  Facelift approach 
 
The patient has had no further episodes of swelling, pain or erythema of the face, and was discharged 
(Fig. 3). 
 
 
 
 
 
 
 
 
 
Fig 3 Clinical appearance post operatively.  
 
 
  
 
Ivy Union Publishing | http: //www.ivyunion.org January 18, 2017 | Volume 4 | Issue 1  
Kennedy H et al.  American Journal of Oral and Maxillofacial Surgery 2017, 4:1-4 
Page 4 of 4 
Discussion 
The adverse effects of dermal facial fillers are well documented, and patient morbidity is rising. In the 
UK the administration of dermal facial fillers has no minimum training requirements, is available 
without prescription, and product quality checks remain insufficient. The Department of Health have 
called the adverse effects of dermal fillers ‘a ticking time bomb’ and ‘a crisis waiting to happen’6. 
 
This case illustrates our experience in a facelift approach for debridement of dermal facial 
fillers. There are many other management techniques documented in the literature, including incision 
and drainage of fluctuant abscesses, antibiotics, and the use of intralesional steroids1,3. The advantages 
of this approach are to minimise visible scarring whilst allowing excellent access to affected areas for 
debridement. The risks include damage to facial nerve leading to temporary or permanent facial 
paralysis. In our experience, good aesthetic results are achieved with this technique.  
Conflict of Interest 
We have no conflict of interest 
Ethics statement/confirmation of patient’s permission 
The patient has given permission. 
References  
1. Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. 
Plast Reconstr Surg. 2006, 118:92S-107S0 
2. Altintas H, Odemis M, Bilgi S, et al. Long-term complications of polyethylene glycol injection to 
the face. Aesthetic Plast Surg. 2012, 36:427-30  
3. Kunjur, J. and Witherow, H. Long-term complications associated with permanent dermal 
fillers. British Journal of Oral and Maxillofacial Surgery. 2013, 51:858-862  
4. Rohrich RJ, Monheit G, Nguyen AT, et al. Soft–tissue filler complications: the important role of 
biofilms. Plast Reconstr Surg 2010;125:1250-6 [Erratum in: Plast Reconstr Surg. 
2010;125:1850]. 
5. BAAPS. Sun, sea and sepsis, Available 
at: http://baaps.org.uk/about-us/press-releases/1734-sun-sea-and-sepsis. 2013 (Accessed: 6th 
November 2016)  
6. Department of Health. Review of the Regulation of Cosmetic Interventions, United Kingdom: 
Department of Health. 2013 
 
